MENU
Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Nov 04, 2026
TickeronGET DAILY SIGNALS
DJD vs SCHD: Weighing Concentrated Yield Against Diversified Quality

DJD vs SCHD: Weighing Concentrated Yield Against Diversified Quality

Key Takeaways

  • Different construction: DJD is a yield-weighted fund of roughly 30 Dow Jones Industrial Average members, while SCHD tracks a quality-screened index of about 100 dividend-paying U.S. stocks.
  • Concentration gap: DJD's top 10 holdings represent roughly 57–60% of assets versus about 40–42% for SCHD, giving DJD materially higher single-stock risk.
  • Cost comparison: Both are low-cost, but SCHD's 0.06% expense ratio slightly undercuts DJD's 0.07%.
  • Sector tilt: DJD is heavily weighted to healthcare, while SCHD spreads exposure more evenly across consumer staples, healthcare, technology, and energy.
  • Scale and liquidity: SCHD holds well over $100 billion in AUM (assets under management), making it far larger and more liquid than DJD.
  • Tickeron AI Verdict: SCHD is the ticker of choice for its superior diversification, quality screening, and cost efficiency.

Why This Comparison Matters Now

Dividend-focused ETFs have drawn renewed attention as investors search for income and lower-volatility equity exposure amid shifting interest-rate expectations. DJD and SCHD are two of the most recognizable names in this space, yet they pursue that goal through very different structures. DJD isolates high-yielding names from the 30-stock Dow Jones Industrial Average, while SCHD applies a disciplined quality screen across a much broader universe of roughly 100 dividend payers. This ETF comparison matters because the two funds are not direct substitutes: one offers concentrated yield, the other offers diversified dividend quality. Understanding their relative positioning helps investors align a fund with their own income and risk objectives.

Understanding DJD

DJD is a passively managed smart-beta fund that tracks the Dow Jones Industrial Average Yield Weighted Index. Rather than replicating the price-weighted Dow, it reweights the index's dividend-paying constituents according to trailing 12-month dividend yield, tilting the portfolio toward the highest-yielding mega-cap names. The fund holds roughly 30 positions and is classified as non-diversified, meaning a handful of issuers can dominate returns.

Top holdings have recently included VZ, MRK, CVX, AMGN, JNJ, IBM, KO, CSCO, UNH, and PG. Sector exposure leans heavily on healthcare, followed by financials, technology, and consumer staples. The expense ratio is 0.07%, and the fund's three-year beta of roughly 0.7 indicates lower sensitivity to broad-market swings than the typical large-cap blend fund. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Understanding SCHD

SCHD is a passively managed fund that tracks the Dow Jones U.S. Dividend 100 Index. Its methodology screens for companies with a record of consecutive annual dividend payments, then ranks them by fundamental quality metrics including cash flow relative to total debt, return on equity (ROE, a measure of profitability), dividend yield, and five-year dividend growth. The result is a portfolio of about 100 holdings weighted by market capitalization.

Recent top holdings have included QCOM, TXN, PG, KO, MRK, CVX, ABT, COP, HD, and UNH. Sector weightings are comparatively balanced across consumer staples, healthcare, technology, and energy. The expense ratio is 0.06%, and the fund's beta of roughly 0.7 reflects its defensive, value-oriented character.

The Broader Market Context

Both funds sit at the intersection of two powerful themes: the persistent investor appetite for yield and a rotation toward value and quality in a higher-for-longer rate environment. Dividend strategies have benefited from steady corporate earnings and record free cash flow among large-cap payers, while energy and healthcare names have provided income and defensive ballast. Regulatory scrutiny of healthcare pricing and volatile commodity prices remain key sector risks. Meanwhile, the income segment has drawn substantial capital flows as investors seek alternatives to cash yields and bonds, supporting the structural appeal of dividend ETFs across recent market cycles.

How Performance and Positioning Compare

Over recent months, both ETFs have participated in the broader value and dividend rally, though their drivers differ. DJD's concentrated yield weighting means its returns are more sensitive to the performance of a handful of high-yielding healthcare and communication names, which can amplify both upside and downside. SCHD's broader, quality-filtered portfolio has historically displayed steadier relative positioning, with less reliance on any single issuer or sector. In periods when mega-cap dividend payers lag, DJD's concentration can create a wider performance gap; when those names lead, the yield tilt can outperform. SCHD's lower top-10 concentration and deeper liquidity generally translate into a smoother volatility profile over full market cycles.

Refining My ETF Analysis with AI Tools

When evaluating dividend strategies like these, I often rely on Tickeron's AI Screener to quickly compare holdings, sector exposures, and risk metrics across similar funds. It allows me to filter by fundamentals, volatility, and AI-driven signals, which helps surface how SCHD stacks up against more concentrated options in real time. This approach keeps the research process efficient without replacing my own judgment on allocation decisions.

Tickeron AI Verdict

Based on structural strength, cost efficiency, diversification profile, and trend consistency, Tickeron's AI would likely favor SCHD over DJD at present. SCHD's roughly 100-stock portfolio offers meaningfully better diversification, a more disciplined quality screen, a marginally lower expense ratio, and substantially greater liquidity and scale. While DJD's yield weighting can deliver higher income and stronger short-term outperformance when high-yielding mega-caps lead, its concentration introduces greater single-stock and sector-specific risk. On a risk-adjusted, probabilistic basis, SCHD's broader exposure and steadier relative positioning give it the more durable profile for most dividend-focused investors.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHD, DJD

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


Momentum Indicator for SCHD turns negative, indicating new downward trend

SCHD saw its Momentum Indicator move below the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In 63 of the 82 cases, the stock moved further down in the following days. The odds of a decline are at 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SCHD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 32 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 64 cases where SCHD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

SCHD broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SCHD just turned positive on October 09, 2026. Looking at past instances where SCHD's MACD turned positive, the stock continued to rise in 40 of 46 cases over the following month. The odds of a continued upward trend are 87%.

SCHD moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.

Following a +0.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 266 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 282 of 364 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Notable companies

The most notable companies in this group are Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), PepsiCo (NASDAQ:PEP), Abbott Laboratories (NYSE:ABT).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF (SCHD) ETF is 57.94B. The market cap for tickers in the group ranges from 363.12M to 417.06B. CVX holds the highest valuation in this group at 417.06B. The lowest valued company is AMSF at 363.12M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was -2%. For the same ETF, the average monthly price growth was 8%, and the average quarterly price growth was 13%. IPAR experienced the highest price growth at 16%, while DVN experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was -13%. For the same stocks of the ETF, the average monthly volume growth was 10% and the average quarterly volume growth was -6%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 43
Price Growth Rating: 43
SMR Rating: 42
Profit Risk Rating: 56
Seasonality Score: 10 (-100 ... +100)